1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with HIV Coinfection in 1 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waldo, CR | 1 |
| McFarland, W | 1 |
| Katz, MH | 1 |
| MacKellar, D | 1 |
| Valleroy, LA | 1 |
1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and HIV Coinfection
| Article | Year |
|---|---|
Very young gay and bisexual men are at risk for HIV infection: the San Francisco Bay Area Young Men's Survey II.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adolescent; Adult; Age Factors; Amphetamines; Bisexual | 2000 |